Kira Clark

Kira Clark

Auto-generated profile, based on publicly available information

Kira Clark

Stanford University School of Medicine Stanford CA USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
JIJoseph‐Kevin Igwe
Joseph‐Kevin Igwe
TYTenzin Yeshi Wangdak Yuthok
Tenzin Yeshi Wangdak Yuthok
ECErin Cruz
Erin Cruz
AMAdrienne Mueller
Adrienne Mueller
RLRoy Hao Lan
Roy Hao Lan
ELEldrin F. Lewis
Eldrin F. Lewis
The United States witnessed a nearly 4‐fold increase in personal health care expenditures between 1980 and 2010. Despite innovations and obvious benefits to health, participants enrolled in clinical trials still do not accurately represent the racial and ethnic composition of patients nationally or globally. This lack of diversity in cohorts limits the generalizability and significance of results among all populations and has deep repercussions for patient equity. To advance diversity in clinical trials, robust evidence for the most effective strategies for recruitment of diverse participants is needed. A major limitation of previous literature on clinical trial diversity is the lack of control or comparator groups for different strategies. To date, interventions have focused primarily on (1) community‐based interventions, (2) institutional practices, and (3) digital health systems. This review article outlines prior intervention strategies across these 3 categories and considers health policy and ethical incentives for substantiation before US Food and Drug Administration approval. There are no current studies that comprehensively compare these interventions against one another. The American Heart Association Strategically Focused Research Network on the Science of Diversity in Clinical Trials represents a multicenter, collaborative network between Stanford School of Medicine and Morehouse School of Medicine created to understand the barriers to diversity in clinical trials by contemporaneous head‐to‐head interventional strategies accessing digital, institutional, and community‐based recruitment strategies to produce informed recruitment strategies targeted to improve underrepresented patient representation in clinical trials.

18 November 2024 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
EBEleanor Bold
Eleanor Bold
KRKelsey L. Richardson
Kelsey L. Richardson
AAAmira Al-Uzri
Amira Al-Uzri
SCSarah F. Craven
Sarah F. Craven
KCKira Clark
Kira Clark
KFKurt A. Freeman
Kurt A. Freeman
Background: Management of pediatric chronic kidney disease (CKD) is complex for affected youth and their families. Treatment requires a high level of family engagement to successfully manage medical appointments, inpatient hospital stays, and daily medication regimens. Health literacy has been identified as a possible contributor to health inequities and unsuccessful chronic disease management. This study sought to explore the perceived health literacy, health-related internet use, and provider trust of children with CKD and their caregivers compared to those without chronic health conditions to inform clinical care. Methods: Caregivers and children completed self-report surveys during routine specialty nephrology and general pediatrics clinic visits. In total, 85 caregivers and 46 youth participated. Statistical analyses included exploration of distributional properties, population differences, and group differences based on self-reported perceived health literacy. Results: Caregiver demographics did not significantly vary across samples. Patient demographics varied significantly across samples with regard to ethnicity. Internet use to find health information was low across samples, and caregivers of children without chronic health conditions endorsed significantly higher perceived health literacy compared to caregivers of children with CKD. Conclusions: Implications for practice include consideration of health literacy when treating children with CKD and patient preparedness for transition to adult care. Graphical

21 November 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
EREli N. Rice
Eli N. Rice
RLRoy H. Lan
Roy H. Lan
JNJulio C. Nunes
Julio C. Nunes
RSRushil Shah
Rushil Shah
KCKira Clark
Kira Clark
PWPaul J. Wang
Paul J. Wang

21 November 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
RLRoy H. Lan
Roy H. Lan
EREli N. Rice
Eli N. Rice
JNJulio C. Nunes
Julio C. Nunes
RSRushil Shah
Rushil Shah
JIJoseph‐Kevin Igwe
Joseph‐Kevin Igwe
PWPaul J. Wang
Paul J. Wang

7 August 2026 in JMIR Formative Research
Verified
Journal Article
Open access
ECErin Rose Cruz
Erin Rose Cruz
TYTenzin Yeshi Wangdak Yuthok
Tenzin Yeshi Wangdak Yuthok
AOAnekwe Onwuanyi
Anekwe Onwuanyi
NVNicholas Vesom
Nicholas Vesom
KCKira Clark
Kira Clark
CBCati Brown-Johnson
Cati Brown-Johnson
Background: Lack of diversity in clinical trials reduces the generalizability of treatment efficacy across different demographic groups, thereby diminishing the relevance, quality, and equity of research findings. Objective: This study aimed to evaluate the implementation of 4 recruitment strategies and their impact on clinical trial enrollment through the Trial of Sites to Increase Diversity in Clinical Trials (TOTAL) project, a collaboration between Stanford and Morehouse School of Medicine funded by the American Heart Association. Methods: Clinical trials were randomized to 1 of 3 recruitment strategy intervention arms (community ambassador, social media ads, or registry and patient engagement platforms) or the control arm (usual recruitment). The Stanford Lightning Report, a rapid qualitative approach, was used to gather insights through interviews with principal investigators (PIs) and trial staff at baseline, 3 months, and trial completion. Results: Trial teams were supportive of increasing diversity and found the recruitment platforms generally user-friendly. External recruitment support was valued, and some trials reported improved access to participants outside their usual pool. Community ambassadors helped connect trials with community and physician networks and, in some cases, increased recruitment of Asian American participants. Registry and patient engagement platforms were easy to use and supported outreach, including direct emails to potential participants. Social media ads, particularly after the transition to BuildClinical (BuildClinical LLC), improved screening efficiency by prescreening candidates and producing a manageable number of eligible leads. Usual recruitment relied mainly on physician referrals and benefited from trusted clinician-patient relationships, but many trials exhausted their typical participant pools. Across strategies, major barriers included limited time, staff capacity, and financial resources; scarcity of diverse local populations; restrictive eligibility criteria; lack of language access; transportation burdens; and limitations of remote engagement. Additional operational barriers included institutional review board (IRB) delays, contract and vendor approval processes, and platform policy restrictions for digital advertising. Feedback from Lightning Reports led to several real-time changes, including a shift from in-house social media outreach to specialized digital recruitment support. Conclusions: Increasing diversity in clinical trials requires sustained financial, human, and institutional support, as well as effective recruitment strategies. Rapid qualitative feedback can identify implementation problems early and support real-time improvements.